Sponsor Pipeline

Collegium Medicum w Bydgoszczy Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 4
1
Phase 3
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07203846 Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in… ACS - Acute Coronary Syndrome Not Yet Recruiting
Phase 3
NCT05905965 Efficacy of Double vs Standard Empapagliflozin Dose for METabolic syndromE tReatment Metabolic Syndrome Recruiting
Not specified
NCT07231939 Use of Flozins (Empagliflozin/Dapagliflozin) for Prevention of AKI Coronary Artery Disease Recruiting
Disease Areas
Coronary Artery Disease (2)
Get alerts when Collegium Medicum w Bydgoszczy's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free